JEROME J. DVONCH - 02 Jan 2025 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Chief Financial Officer
Signature
/s/ Jerome Dvonch
Issuer symbol
SNOA
Transactions as of
02 Jan 2025
Net transactions value
$0
Form type
4
Filing time
03 Jan 2025, 17:02:05 UTC
Previous filing
21 Jun 2024
Next filing
20 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNOA Restricted Stock Units Award $0 +10,000 +170% $0.000000 15,891 02 Jan 2025 Common Stock 10,000 $0.000000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock.
F2 The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control.
F3 The RSUs were awarded and granted to Mr. Dvonch for services performed as part of the Company's annual equity grant.